Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma.
Kuo HY, Han MZ, Liao CH, Lin YJ, Wang CT, Chen SH, Chang TT, Chen PJ, Lin SH, Chen CY, Chuang CH, Wu IC, Wu JS, Hong TC, Hsieh MT, Lee YC, Wu HT, Tsai HM.
Kuo HY, et al. Among authors: chen sh, chen cy, chen pj.
Pharmaceutics. 2022 Oct 23;14(11):2263. doi: 10.3390/pharmaceutics14112263.
Pharmaceutics. 2022.
PMID: 36365082
Free PMC article.